Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

Integrative profiling of t-follicular helper cells heterogeneity and tumor microenvironment signatures in angioimmunoblastic T cell lymphoma

Tania Sainz, Vakul Mohanty, Yuchen Pan, Xuehong Gui, Vishal Sahu, Anna Casasent, Akshay Basi, Claudia Kettlun, Christopher Pacheco, Ashley Wilson, Juan Andres Donoso, Aniruddha Mundhada, Jared Henderson, Yago Nieto, Jared Burks, Michael R Green, Ken Chen, Francisco Vega

Blood (2025) 146 (Supplement 1): 555.

https://doi.org/10.1182/blood-2025-555

Published: 2025

Journal Articles

Acalabrutinib plus rituximab followed by brexucabtagene autoleucel for frontline treatment of high-risk Mantle Cell Lymphoma: The window-3 clinical trial

Blood (2025) 146 (Supplement 1): 666.

https://doi.org/10.1182/blood-2025-666

Published: 2025

Journal Articles

primary analysis of the smart stop trial: Lenalidomide, tafasitamab, rituximab, and acalabrutinib alone and with combination chemotherapy in newly diagnosed diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 477.

https://doi.org/10.1182/blood-2025-477

Published: 2025

Journal Articles

Epigenetically driven upregulation of immunoproteasome component PSMB8 characterizes diffuse large B-cell lymphoma (DLBCL) with inflammatory microenvironment in African ancestry patients

María Revuelta, Ines Mota, Vishal Sahu, Tania Sainz, Kumudha Balakrishnan, Federico Ruiz Moreno, Nahuel Zamponi, Francisco Vega, Christopher Flowers, Leandro Cerchietti

Blood (2025) 146 (Supplement 1): 3674.

https://doi.org/10.1182/blood-2025-3674

Published: 2025

Journal Articles

Venetoclax-based therapies in patients with Relapsed/Refractory T-cell prolymphocytic leukemia

Roberta S. Azevedo, Caitlin Rausch, Alexis Geppner, Francisco Vega, Deepa Sampath, Alessandra Ferrajoli, Kelly Chien, Elias Jabbour, Danielle Hammond, Nicholas Short, Koichi Takahashi, Nitin Jain, Jan Burger, Gautam Borthakur, William Wierda, Chitra Hosing, Farhad Ravandi, Tapan Kadia

Blood (2025) 146 (Supplement 1): 3653.

https://doi.org/10.1182/blood-2025-3653

Published: 2025

Journal Articles

Targeting B- and T-cell lymphomas with anti-CXCR5 CAR T cell therapy

Blood (2025) 146 (Supplement 1): 3709.

https://doi.org/10.1182/blood-2025-3709

Published: 2025

Journal Articles

Loss of p53 enhances LMO2 induced transdifferentiation of B-cells to T-cell acute lymphoblastic leukemia

Izidore S. Lossos, Shlomzion Aumann, Andrew Gentles, Francisco Vega, Carolina Vicente-Dueñas, Hsuan-Ting Huang, Raymond Terryn, Sandro Satta, Brooks Benard, Ramiro Verdun, Isidro Sanchez-Garcia, Daniel Bilbao

Blood (2025) 146 (Supplement 1): 142.

https://doi.org/10.1182/blood-2025-142

Published: 2025

Journal Articles

KIR3DL2-directed CAR T cell therapy for T cell malignancies

Blood (2025) 146 (Supplement 1): 7621.

https://doi.org/10.1182/blood-2025-7621

Published: 2025

Journal Articles

Long-term clinical outcomes from the smart start trial: Rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 3691.

https://doi.org/10.1182/blood-2025-3691

Published: 2025

Journal Articles

MYC/GSPT1 protein degradation in refractory/relapsed T-cell prolymphocytic leukemias

Yuki Nishida, Claudia Kettlun, Lauren Ostermann, Tapan Kadia, Michael Andreeff, Francisco Vega

Blood (2025) 146 (Supplement 1): 3314.

https://doi.org/10.1182/blood-2025-3314

Published: 2025

Journal Articles

Sasp-driven immune evasion defines a novel African ancestry-associated DLBCL subtype with distinctive molecular and immune vulnerabilities

Blood (2025) 146 (Supplement 1): 3.

https://doi.org/10.1182/blood-2025-3

Published: 2025

Journal Articles

Immune effector cell-associated enterocolitis (IEC-EC) across CAR-T products in myeloma and lymphoma: A real world pharmacovigilance analysis

Medha Belwadi, Mark Hamilton, Yinghong Wang, Sairah Ahmed, David Richards, Rahul Banerjee, Nilesh Kalariya, Baldeep Pabla, Neeraj Saini, Oren Pasvolsky, J Christine Ye, Mahmoud Gaballa, Sa Wang, L. Jeffrey Medeiros, Francisco Vega, Krina Patel, Swami Iyer

Blood (2025) 146 (Supplement 1): 6366.

https://doi.org/10.1182/blood-2025-6366

Published: 2025

Journal Articles

A novel CD94-targeting CAR T cell therapy for cytotoxic subtypes of T/NK-cell malignancies

Blood (2025) 146 (Supplement 1): 2337.

https://doi.org/10.1182/blood-2025-2337

Published: 2025

Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood (2024) 144 (19): 2063–2066.

https://doi.org/10.1182/blood.2024025681

Published: 2024

Includes: Supplemental data

Journal Articles

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3038.

https://doi.org/10.1182/blood-2024-206042

Published: 2024

Journal Articles

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica

Blood (2024) 144 (Supplement 1): 1674.3.

https://doi.org/10.1182/blood-2024-212005

Published: 2024

Journal Articles

Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Eduardo Edelman Saul, Bryan Valcarcel, Amy A. Ayers, Mansoor Noorani, Dai Chihara, Fateeha Furqan, Sairah Ahmed, Swaminathan P Iyer, Sattva S. Neelapu, Luis E. Fayad, F. B. Hagemeister, Chijioke Nze, Preetesh Jain, Michael Wang, Paolo Strati, Ayushi Chauhan, Francisco Vega, Christopher R. Flowers, Jason R. Westin

Blood (2024) 144 (Supplement 1): 4454.

https://doi.org/10.1182/blood-2024-211247

Published: 2024

Journal Articles

Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors In Vivo

Claudia Kettlun, Daniel Galvan, Jie Xu, Tania P Sainz Zuniga, Sebastian Juarez-Casillas, Daisy Y. Diaz Rohena, Vishal Sahu, Juan Andres Donoso, Arrate Zubero, Estela Rojas-Neira, David Blake, Jared Henderson, Michael Green, Tapan M. Kadia, Deepa Sampath, Francisco Vega

Blood (2024) 144 (Supplement 1): 4373.

https://doi.org/10.1182/blood-2024-193372

Published: 2024

Journal Articles

Multiomic Single Cell Profiling Identifies Drivers of Progression in T-Cell Prolymphocytic Leukemia

Vishakha Anand Pawar, Arnau Peris Cuesta, Akanksha Aradhya, Claudia Kettlun, Swaminathan P Iyer, Sachet Shukla, Tapan M. Kadia, Francisco Vega, Deepa Sampath

Blood (2024) 144 (Supplement 1): 6230.

https://doi.org/10.1182/blood-2024-208729

Published: 2024

Journal Articles

Venetoclax As a Combination Partner with NAMPT Inhibitor Rpt-1G for T-ALL

John R. Sanchez, II, Daisy Y. Diaz Rohena, Charmelle D. Williams, Valerio Ciaurro, Min Wu, Francis Roushar, Dennise A. De Jesús-Díaz, Gregory Crimmins, Vinay Puduvalli, Francisco Vega, Palaniraja Thandapani, Deepa Sampath

Blood (2024) 144 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2024-208190

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Integrative profiling of t-follicular helper cells heterogeneity and tumor microenvironment signatures in angioimmunoblastic T cell lymphoma

Acalabrutinib plus rituximab followed by brexucabtagene autoleucel for frontline treatment of high-risk Mantle Cell Lymphoma: The window-3 clinical trial

primary analysis of the smart stop trial: Lenalidomide, tafasitamab, rituximab, and acalabrutinib alone and with combination chemotherapy in newly diagnosed diffuse large B-cell lymphoma

Epigenetically driven upregulation of immunoproteasome component PSMB8 characterizes diffuse large B-cell lymphoma (DLBCL) with inflammatory microenvironment in African ancestry patients

Venetoclax-based therapies in patients with Relapsed/Refractory T-cell prolymphocytic leukemia

Targeting B- and T-cell lymphomas with anti-CXCR5 CAR T cell therapy

Loss of p53 enhances LMO2 induced transdifferentiation of B-cells to T-cell acute lymphoblastic leukemia

KIR3DL2-directed CAR T cell therapy for T cell malignancies

Long-term clinical outcomes from the smart start trial: Rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma

MYC/GSPT1 protein degradation in refractory/relapsed T-cell prolymphocytic leukemias

Sasp-driven immune evasion defines a novel African ancestry-associated DLBCL subtype with distinctive molecular and immune vulnerabilities

Immune effector cell-associated enterocolitis (IEC-EC) across CAR-T products in myeloma and lymphoma: A real world pharmacovigilance analysis

A novel CD94-targeting CAR T cell therapy for cytotoxic subtypes of T/NK-cell malignancies

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors In Vivo

Multiomic Single Cell Profiling Identifies Drivers of Progression in T-Cell Prolymphocytic Leukemia

Venetoclax As a Combination Partner with NAMPT Inhibitor Rpt-1G for T-ALL

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only